Safety Labeling Changes—Implementation of Section 505(o)(4) of the FD&C Act

This draft guidance provides information on the implementation of the statutory provision that authorizes FDA to require application holders for certain drug and biological products to make labeling changes based on new safety information that becomes available after approval of the drug.